TISLELIZUMAB

UNII:	0KVO411B3N
Formula:
Preferred Substance Name:	TISLELIZUMAB

1858168-59-8
BGBA317
BGBA-317
BGB-A317
BGN1
BGN-1
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) SYNTHETIC CLONE 317-4B6 HEAVY CHAIN VH FRAGMENT FUSION PROTEIN WITH HUMAN .GAMMA.4 CHAIN CLONE MUT10 EFFECTOR/CONSTANT DOMAIN FRAGMENT, DISULFIDE WITH ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) SYNTHETIC CLONE 317-4B6 LIGHT CHAIN VL FRAGMENT FUSION PROTEIN WITH HUMAN .KAPPA. CHAIN CONSTANT REGION FRAGMENT, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), HUMANIZED MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-445) (HUMANIZED VH (HOMO SAPIENS IGHV4-59*01 (88.70%) -(IGHD) -IGHJ3*01 M123>T (113)) (8.7.12) (1-118) -HOMO SAPIENS IGHG4*01 (CH1 (119-216), HINGE S10>P (226) (217-228), CH2 E1.4>P (231), F1.3>V (232), L1.2>A (233), D27>A (263) (229-338), CH3 R88>K (407) (339-443), CHS (444-445)) (119-445)), (132-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'- 214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV4-1*01 (81.20%) -IGKJ2*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01, KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (224-224'':227-227'')-BISDISULFIDE
JHL2108
JHL-2108
TEVIMBRA
TISLELIZUMAB [INN]
TISLELIZUMAB [USAN]
TISLELIZUMAB [WHO-DD]
TISLELIZUMAB-JSGR

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TISLELIZUMAB

Synonyms and Mappings

Resources